#151447

CMT 64 Cell Line

Cat. #151447

CMT 64 Cell Line

Cat. #: 151447

Unit size: 1x10^6 cells / vial

Organism: Mouse

Tissue: Lung

Disease: Cancer

Model: Tumour line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Riddle

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: CMT 64 Cell Line
  • Cancer: Lung cancer
  • Cancers detailed: Lung carcinoma;Metastatic
  • Research fields: Cancer;Drug development
  • Organism: Mouse
  • Tissue: Lung
  • Disease: Cancer
  • Growth properties: Tumorigenesis
  • Model: Tumour line
  • Description: The tumourigenic and metastatic CMT 64 murine cell line is an in vivo mouse tumourigenesis system to study the growth characteristics and metastasis of mouse tumour lines (homoplastic with stable CMT 167 line); it demonstrates stable growth characteristics and morphology in culture and in lung metastasis induced after subcutaneous inoculation of mice.
  • Production details: Mouse; CMT 64 isolated from primary alveogenic lung carcinoma tumour mass in C57BL/lcrf mouse, achieving stable morphology and growth rate in culture, similar to growth rate and morphology in primary tumour, and in lung metastasis induced after subcutaneous innoculation of mice.
  • Cellosaurus id: CVCL_2406

Handling

  • Format: Frozen
  • Growth medium: CMT 64 cell line can be grown in DMEM with 10% FCS, supplemented with 20mM Hepes.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: CMT 64/61 Cell Line ; CMT 170 Cell Line

References

  • Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
  • Rincn et al. 2017. Oncotarget. :. PMID: 28525366.
  • Franks et al. 1976. Cancer Res. 36(3):1049-55. PMID: 1253168.
  • Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor.